SynCore Bio Doses First Patient In Phase III Trial for SB05 Pancreatic Cancer in South Korea Taipei, Taiwan, 25 December 2018. SynCore Biotechnology Co. (4192:TT) [...] Merissa2019-01-03T18:52:50+08:00December 25th, 2018|Press Release| Read More
